EXAME, Brazil’s leading business magazine, recently released their annual 1000 Biggest and Best Companies in Brazil list, which highlights the largest and best performing companies in the country. Zoetis is featured on the list for the third year in a row, with improved rankings from previous years.
Corporate Feature Stories
Following four years of extreme drought conditions, California's vulnerability to wildfires fires has drastically increased. In mid-September, the Valley fires of Northern California destroyed an...
On September 22, Zoetis was named among the top ten on Working Mother magazine’s "100 Best Companies for Working Mothers" list for the second consecutive year.
Zoetis joined the conversation at the 2015 World Exposition (Expo Milano), contributing to advancing solutions to help the world’s livestock farmers produce more with less.
Zoetis recently sponsored the DOGRUN event in Argentina, which aimed to raise awareness among dog owners about the importance of regular veterinary care for their pets.
Zoetis marked the completion of a 19,000-square-foot, three-story expansion at its manufacturing site in Lincoln, Nebraska.
Dr. Catherine Knupp, executive vice president and president of Research and Development at Zoetis, shares her insights on the value of innovation to both animal and human health.
Clint Lewis, Executive Vice President and President, U.S.
RIMADYL K-9 Courage Program™ provides medical assistance for dogs who served us
Feedinfo News Service, a provider of Business and Scientific information for global corporations serving the Agribusiness and Biotechnology sectors, recently spoke to Zoetis CEO Juan Ramó
Zoetis has created a new network to identify and quickly address emerging infectious diseases in livestock and companion animals, and enhance the ability to rapidly respond and help control them.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.